This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Generics (UK) Limited. Active years: 2015-2016.
Company Filing History:
Years Active: 2015-2016
Title: Innovations of Madhav Jadhav in Pharmaceutical Chemistry
Introduction
Madhav Jadhav is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of erlotinib and its derivatives. With a total of two patents to his name, Jadhav's work has implications for medical applications and pharmaceutical compositions.
Latest Patents
Jadhav's latest patents focus on the preparation of erlotinib and its salts and polymorphs. The first patent details processes for the preparation of erlotinib and emphasizes its medical uses, as well as the pharmaceutical compositions that include these compounds. The second patent also relates to the preparation of erlotinib, specifically highlighting the importance of achieving high purity in the final product.
Career Highlights
Throughout his career, Madhav Jadhav has worked with prominent companies in the pharmaceutical sector, including Generics (UK) Limited. His experience in these organizations has allowed him to refine his expertise in drug development and formulation.
Collaborations
Jadhav has collaborated with several professionals in his field, including Vinayak Govind Gore and Anilkumar Tripathi. These collaborations have likely contributed to the advancement of his research and innovations.
Conclusion
Madhav Jadhav's contributions to pharmaceutical chemistry, particularly through his patents on erlotinib, showcase his innovative spirit and dedication to improving medical treatments. His work continues to influence the pharmaceutical industry and highlights the importance of research and development in healthcare.